# RDF export of group: Publication
<http://ctro/data#Publication_74641> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Publication> .
<http://ctro/data#Publication_74641> <http://www.w3.org/2000/01/rdf-schema#label> "Publication 74641" .
<http://ctro/data#Publication_74641> <http://ctro/data#hasTitle> "Efficacy and Safety of LixiLan , a Titratable Fixed - Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin : The LixiLan - L Randomized Trial ." .
<http://ctro/data#Publication_74641> <http://ctro/data#hasAuthor> "Aroda VR" .
<http://ctro/data#Publication_74641> <http://ctro/data#hasPublicationYear> "2016" .
<http://ctro/data#Publication_74641> <http://ctro/data#hasJournal> "Diabetes Care" .
<http://ctro/data#Publication_74641> <http://ctro/data#hasPMID> "27650977" .
<http://ctro/data#Publication_74641> <http://ctro/data#describes> <http://ctro/data#ClinicalTrial_74648> .
<http://ctro/data#Publication_74641> <http://ctro/data#hasAuthor> "Rosenstock J" .
<http://ctro/data#Publication_74641> <http://ctro/data#hasAuthor> "Wysham C" .
<http://ctro/data#Publication_74641> <http://ctro/data#hasAuthor> "Unger J" .
<http://ctro/data#Publication_74641> <http://ctro/data#hasAuthor> "Bellido D" .
<http://ctro/data#Publication_74641> <http://ctro/data#hasAuthor> "Gonz á lez - G á lvez G" .
<http://ctro/data#Publication_74641> <http://ctro/data#hasAuthor> "Takami A" .
<http://ctro/data#Publication_74641> <http://ctro/data#hasAuthor> "Guo H" .
<http://ctro/data#Publication_74641> <http://ctro/data#hasAuthor> "Niemoeller E" .
<http://ctro/data#Publication_74641> <http://ctro/data#hasAuthor> "Souhami E" .
<http://ctro/data#Publication_74641> <http://ctro/data#hasAuthor> "Bergenstal RM" .
# RDF export of group: ClinicalTrial
<http://ctro/data#ClinicalTrial_74648> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#ClinicalTrial> .
<http://ctro/data#ClinicalTrial_74648> <http://www.w3.org/2000/01/rdf-schema#label> "ClinicalTrial 74648" .
<http://ctro/data#ClinicalTrial_74648> <http://ctro/data#hasObjectiveDescription> "This study was conducted to demonstrate the efficacy and safety of LixiLan ( iGlarLixi ) , a novel , titratable , fixed - ratio combination of insulin glargine ( iGlar ) ( 100 units ) and lixisenatide ," .
<http://ctro/data#ClinicalTrial_74648> <http://ctro/data#hasNumberPatientsCT> "736" .
<http://ctro/data#ClinicalTrial_74648> <http://ctro/data#hasCTduration> "30 weeks" .
<http://ctro/data#AllocationRatio_74652> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#AllocationRatio> .
<http://ctro/data#ClinicalTrial_74648> <http://ctro/data#hasAllocationRatio> <http://ctro/data#AllocationRatio_74652> .
<http://ctro/data#CTAnalysisApproach_74653> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#CTAnalysisApproach> .
<http://ctro/data#ClinicalTrial_74648> <http://ctro/data#hasCTDesign> <http://ctro/data#Randomized> .
<http://ctro/data#ClinicalTrial_74648> <http://ctro/data#hasConclusionComment> "Compared with iGlar , a substantially higher proportion of iGlarLixi - treated patients achieved glycemic targets with a beneficial effect on body weight , no additional risk of hypoglycemia ," .
<http://ctro/data#ClinicalTrial_74648> <http://ctro/data#hasArm> <http://ctro/data#Arm_74672> .
<http://ctro/data#ClinicalTrial_74648> <http://ctro/data#analysesHealthCondition> <http://ctro/data#Type2Diabetes> .
<http://ctro/data#ClinicalTrial_74648> <http://ctro/data#hasPopulation> <http://ctro/data#Population_74664> .
<http://ctro/data#ClinicalTrial_74648> <http://ctro/data#hasDiffBetweenGroups> <http://ctro/data#DiffBetweenGroups_74805> .
<http://ctro/data#EvidenceQuality_74660> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EvidenceQuality> .
<http://ctro/data#ClinicalTrial_74648> <http://ctro/data#hasArm> <http://ctro/data#Arm_74681> .
<http://ctro/data#ClinicalTrial_74648> <http://ctro/data#hasConclusionComment> "and low levels of gastrointestinal adverse effects in inadequately controlled , basal insulin - treated , long - standing type 2 diabetes ." .
<http://ctro/data#ClinicalTrial_74648> <http://ctro/data#hasCTDesign> <http://ctro/data#OpenLabel> .
<http://ctro/data#ClinicalTrial_74648> <http://ctro/data#hasObjectiveDescription> "compared with iGlar in patients with type 2 diabetes inadequately controlled on basal insulin with or without up to two oral glucose - lowering agents ." .
<http://ctro/data#ClinicalTrial_74648> <http://ctro/data#hasDiffBetweenGroups> <http://ctro/data#DiffBetweenGroups_74932> .
# RDF export of group: Population
<http://ctro/data#Population_74664> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Population> .
<http://ctro/data#Population_74664> <http://www.w3.org/2000/01/rdf-schema#label> "Population 74664" .
<http://ctro/data#Population_74664> <http://ctro/data#hasPrecondition> "Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin" .
<http://ctro/data#Ethnicity_74666> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Ethnicity> .
<http://ctro/data#Country_74667> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Country> .
<http://ctro/data#Gender_74671> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Gender> .
<http://ctro/data#Population_74664> <http://ctro/data#hasPrecondition> "patients with type 2 diabetes inadequately controlled on basal insulin with or without up to two oral glucose - lowering agents" .
# RDF export of group: Endpoint
<http://ctro/data#Endpoint_74746> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Endpoint> .
<http://ctro/data#Endpoint_74746> <http://www.w3.org/2000/01/rdf-schema#label> "hba" .
<http://ctro/data#Endpoint_74746> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#HbA1c> .
<http://ctro/data#Mean_74748> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Mean> .
<http://ctro/data#Endpoint_74746> <http://ctro/data#hasAggregationMethod> <http://ctro/data#Mean_74748> .
<http://ctro/data#Endpoint_74746> <http://ctro/data#hasBaselineUnit> <http://ctro/data#Percentage> .
<http://ctro/data#MeasurementDevice_74750> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#MeasurementDevice> .
<http://ctro/data#Endpoint_74814> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Endpoint> .
<http://ctro/data#Endpoint_74814> <http://www.w3.org/2000/01/rdf-schema#label> "hbat" .
<http://ctro/data#Endpoint_74814> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#HbA1c_target> .
<http://ctro/data#AggregationMethod_74816> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#AggregationMethod> .
<http://ctro/data#BioAndMedicalUnit_74817> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#BioAndMedicalUnit> .
<http://ctro/data#MeasurementDevice_74818> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#MeasurementDevice> .
<http://ctro/data#Endpoint_74873> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Endpoint> .
<http://ctro/data#Endpoint_74873> <http://www.w3.org/2000/01/rdf-schema#label> "bw" .
<http://ctro/data#Endpoint_74873> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#BodyWeight> .
<http://ctro/data#Mean_74875> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Mean> .
<http://ctro/data#Endpoint_74873> <http://ctro/data#hasAggregationMethod> <http://ctro/data#Mean_74875> .
<http://ctro/data#Endpoint_74873> <http://ctro/data#hasBaselineUnit> <http://ctro/data#Kg> .
<http://ctro/data#MeasurementDevice_74877> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#MeasurementDevice> .
<http://ctro/data#Endpoint_74941> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Endpoint> .
<http://ctro/data#Endpoint_74941> <http://www.w3.org/2000/01/rdf-schema#label> "hyp" .
<http://ctro/data#Endpoint_74941> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#SymptomaticHypoglycemia> .
<http://ctro/data#AggregationMethod_74943> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#AggregationMethod> .
<http://ctro/data#BioAndMedicalUnit_74944> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#BioAndMedicalUnit> .
<http://ctro/data#MeasurementDevice_74945> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#MeasurementDevice> .
<http://ctro/data#Endpoint_75000> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Endpoint> .
<http://ctro/data#Endpoint_75000> <http://www.w3.org/2000/01/rdf-schema#label> "gas" .
<http://ctro/data#Endpoint_75000> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#GastrointestinalProblem> .
<http://ctro/data#AggregationMethod_75002> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#AggregationMethod> .
<http://ctro/data#BioAndMedicalUnit_75003> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#BioAndMedicalUnit> .
<http://ctro/data#MeasurementDevice_75004> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#MeasurementDevice> .
# RDF export of group: Arm
<http://ctro/data#Arm_74672> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Arm> .
<http://ctro/data#Arm_74672> <http://www.w3.org/2000/01/rdf-schema#label> "lix" .
<http://ctro/data#Arm_74672> <http://ctro/data#hasIntervention> <http://ctro/data#Intervention_74690> .
<http://ctro/data#Arm_74672> <http://ctro/data#hasOutcome> <http://ctro/data#Outcome_74751> .
<http://ctro/data#Arm_74672> <http://ctro/data#hasAdverseEffect> <http://ctro/data#Outcome_74946> .
<http://ctro/data#Arm_74672> <http://ctro/data#hasOutcome> <http://ctro/data#Outcome_74819> .
<http://ctro/data#Arm_74672> <http://ctro/data#hasOutcome> <http://ctro/data#Outcome_74878> .
<http://ctro/data#Arm_74672> <http://ctro/data#hasAdverseEffect> <http://ctro/data#Outcome_75005> .
<http://ctro/data#Arm_74681> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Arm> .
<http://ctro/data#Arm_74681> <http://www.w3.org/2000/01/rdf-schema#label> "gl" .
<http://ctro/data#Arm_74681> <http://ctro/data#hasIntervention> <http://ctro/data#Intervention_74696> .
<http://ctro/data#Arm_74681> <http://ctro/data#hasOutcome> <http://ctro/data#Outcome_74778> .
<http://ctro/data#Arm_74681> <http://ctro/data#hasAdverseEffect> <http://ctro/data#Outcome_74973> .
<http://ctro/data#Arm_74681> <http://ctro/data#hasOutcome> <http://ctro/data#Outcome_74846> .
<http://ctro/data#Arm_74681> <http://ctro/data#hasOutcome> <http://ctro/data#Outcome_74905> .
# RDF export of group: Intervention
<http://ctro/data#Intervention_74690> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Intervention> .
<http://ctro/data#Intervention_74690> <http://www.w3.org/2000/01/rdf-schema#label> "lix" .
<http://ctro/data#Intervention_74690> <http://ctro/data#hasMedication> <http://ctro/data#Medication_74702> .
<http://ctro/data#Intervention_74690> <http://ctro/data#hasFrequency> "once - daily" .
<http://ctro/data#RelativeTime_74695> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#RelativeTime> .
<http://ctro/data#Intervention_74696> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Intervention> .
<http://ctro/data#Intervention_74696> <http://www.w3.org/2000/01/rdf-schema#label> "gla" .
<http://ctro/data#Intervention_74696> <http://ctro/data#hasMedication> <http://ctro/data#Medication_74709> .
<http://ctro/data#Intervention_74696> <http://ctro/data#hasFrequency> "once - daily" .
<http://ctro/data#RelativeTime_74701> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#RelativeTime> .
# RDF export of group: Medication
<http://ctro/data#Medication_74702> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Medication> .
<http://ctro/data#Medication_74702> <http://www.w3.org/2000/01/rdf-schema#label> "lix" .
<http://ctro/data#FixedCombDrug_74703> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#FixedCombDrug> .
<http://ctro/data#Medication_74702> <http://ctro/data#hasDrug> <http://ctro/data#FixedCombDrug_74703> .
<http://ctro/data#Medication_74702> <http://ctro/data#hasDoseUnit> <http://ctro/data#Int_Unit> .
<http://ctro/data#DeliveryMethod_74706> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#DeliveryMethod> .
<http://ctro/data#Medication_74702> <http://ctro/data#hasDoseDescription> "titrated to fasting plasma glucose < 100 mg / dL ( < 5 . 6 mmol / L ) up to a maximum dose of 60 units / day" .
<http://ctro/data#Medication_74709> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Medication> .
<http://ctro/data#Medication_74709> <http://www.w3.org/2000/01/rdf-schema#label> "gla" .
<http://ctro/data#Medication_74709> <http://ctro/data#hasDrug> <http://ctro/data#InsulinGlargine> .
<http://ctro/data#Medication_74709> <http://ctro/data#hasDoseUnit> <http://ctro/data#Int_Unit> .
<http://ctro/data#DeliveryMethod_74713> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#DeliveryMethod> .
<http://ctro/data#Medication_74709> <http://ctro/data#hasDoseDescription> "titrated to fasting plasma glucose < 100 mg / dL ( < 5 . 6 mmol / L ) up to a maximum dose of 60 units / day" .
# RDF export of group: Outcome
<http://ctro/data#Outcome_74751> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_74751> <http://www.w3.org/2000/01/rdf-schema#label> "hba 1" .
<http://ctro/data#Outcome_74751> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_74746> .
<http://ctro/data#Outcome_74751> <http://ctro/data#hasResultMeasuredValue> "6 . 9" .
<http://ctro/data#Outcome_74751> <http://ctro/data#hasChangeValue> "1 . 1" .
<http://ctro/data#Outcome_74778> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_74778> <http://www.w3.org/2000/01/rdf-schema#label> "hba 2" .
<http://ctro/data#Outcome_74778> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_74746> .
<http://ctro/data#Outcome_74778> <http://ctro/data#hasResultMeasuredValue> "7 . 5" .
<http://ctro/data#Outcome_74778> <http://ctro/data#hasChangeValue> "0 . 6" .
<http://ctro/data#Outcome_74819> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_74819> <http://www.w3.org/2000/01/rdf-schema#label> "hbat 1" .
<http://ctro/data#Outcome_74819> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_74814> .
<http://ctro/data#Outcome_74819> <http://ctro/data#hasPercentageAffected> "55" .
<http://ctro/data#Outcome_74846> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_74846> <http://www.w3.org/2000/01/rdf-schema#label> "hbat 2" .
<http://ctro/data#Outcome_74846> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_74814> .
<http://ctro/data#Outcome_74846> <http://ctro/data#hasPercentageAffected> "30" .
<http://ctro/data#Outcome_74878> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_74878> <http://www.w3.org/2000/01/rdf-schema#label> "bw 1" .
<http://ctro/data#Outcome_74878> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_74873> .
<http://ctro/data#Outcome_74878> <http://ctro/data#hasChangeValue> "0 . 7" .
<http://ctro/data#Outcome_74905> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_74905> <http://www.w3.org/2000/01/rdf-schema#label> "bw 2" .
<http://ctro/data#Outcome_74905> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_74873> .
<http://ctro/data#Outcome_74905> <http://ctro/data#hasChangeValue> "0 . 7" .
<http://ctro/data#Outcome_74946> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_74946> <http://www.w3.org/2000/01/rdf-schema#label> "hyp 1" .
<http://ctro/data#Outcome_74946> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_74941> .
<http://ctro/data#Outcome_74946> <http://ctro/data#hasObservedResult> "Documented symptomatic hypoglycemia ( ≤ 70 mg / dL ) was comparable between groups ." .
<http://ctro/data#Outcome_74973> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_74973> <http://www.w3.org/2000/01/rdf-schema#label> "hyp 2" .
<http://ctro/data#Outcome_74973> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_74941> .
<http://ctro/data#Outcome_74973> <http://ctro/data#hasObservedResult> "Documented symptomatic hypoglycemia ( ≤ 70 mg / dL ) was comparable between groups ." .
<http://ctro/data#Outcome_75005> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_75005> <http://www.w3.org/2000/01/rdf-schema#label> "gas 1" .
<http://ctro/data#Outcome_75005> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_75000> .
<http://ctro/data#Outcome_75005> <http://ctro/data#hasObservedResult> "Mild gastrointestinal adverse effects were very low but more frequent with iGlarLixi ." .
# RDF export of group: DiffBetweenGroups
<http://ctro/data#DiffBetweenGroups_74805> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#DiffBetweenGroups> .
<http://ctro/data#DiffBetweenGroups_74805> <http://www.w3.org/2000/01/rdf-schema#label> "hba" .
<http://ctro/data#DiffBetweenGroups_74805> <http://ctro/data#hasPvalueDiff> "P < 0 . 0001" .
<http://ctro/data#DiffBetweenGroups_74805> <http://ctro/data#hasOutcome1> <http://ctro/data#Outcome_74751> .
<http://ctro/data#DiffBetweenGroups_74805> <http://ctro/data#hasOutcome2> <http://ctro/data#Outcome_74778> .
<http://ctro/data#DiffBetweenGroups_74932> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#DiffBetweenGroups> .
<http://ctro/data#DiffBetweenGroups_74932> <http://www.w3.org/2000/01/rdf-schema#label> "bw" .
<http://ctro/data#DiffBetweenGroups_74932> <http://ctro/data#hasDiffGroupAbsValue> "1 . 4" .
<http://ctro/data#DiffBetweenGroups_74932> <http://ctro/data#hasPvalueDiff> "P < 0 . 0001" .
<http://ctro/data#DiffBetweenGroups_74932> <http://ctro/data#hasOutcome1> <http://ctro/data#Outcome_74878> .
<http://ctro/data#DiffBetweenGroups_74932> <http://ctro/data#hasOutcome2> <http://ctro/data#Outcome_74905> .
# RDF export of group: EvidenceQuality